[{"Assets_0_Q3_USD":76553000.0,"CommonStockSharesOutstanding_0_Q3_shares":30833367.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-18669000.0,"NetIncomeLoss_1_Q3_USD":-9011000.0,"NetIncomeLoss_3_Q3_USD":-22386000.0,"StockholdersEquity_0_Q3_USD":60718000.0,"Ticker":"VRDN","CIK":"1590750","name":"MIRAGEN THERAPEUTICS, INC.","OfficialName":"Viridian Therapeutics Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"445189274.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181107"}]